Yes — Formal Quantification of Proteinuria is Absolutely Necessary

Why Dipstick 3+ Is Not Enough

• Concentrated urine (as in hypertensive patients with reduced renal perfusion) → false-positive or overestimated result
• Alkaline urine (pH ≥7.0) → false-positive results
• Blood contamination → false-positive
• Dipstick predominantly detects albumin only — it misses non-albumin proteins (light chains, tubular proteins), so a plasma cell dyscrasia (myeloma, amyloidosis — highly relevant in a 67M!) could be partially missed

"Conventional dipsticks detect predominantly albumin and provide a semiquantitative assessment (trace, 1+, 2+, or 3+), which is influenced by urinary concentration as reflected by urine specific gravity." — Harrison's Principles of Internal Medicine 22E

What Formal Quantification Gives You

"Quantification of urinary protein excretion is important in individuals with persistent proteinuria to help narrow the spectrum of kidney injury (benign proteinuria vs. non-nephrotic proteinuria vs. nephrotic syndrome) and to monitor progression of disease and response to treatment over time." — NKF Primer on Kidney Diseases, 8e

This Patient's Specific Context

Recommended Proteinuria Workup

1. Spot first-morning urine PCR — most practical, KDIGO-endorsed
2. Spot uACR simultaneously — compare with uPCR; if uPCR >> uACR, think Bence Jones
3. UPEP / UIFE — mandatory to exclude overflow proteinuria from plasma cell dyscrasia
4. Serum protein electrophoresis (SPEP) + free light chains — part of same myeloma screen
5. 24-hour urine — if spot ratio is inconsistent or creatinine excretion unreliable (elderly, cachectic)

"A comparison of the microalbumin-to-creatinine ratio with the protein-to-creatinine ratio will give an insight into the presence of Bence Jones protein because of the absence of albuminuria despite significant proteinuria." — Goldman-Cecil Medicine

Practical Answer to Your Question

• Dipstick 3+ is the starting signal, not the conclusion.
• In this 67M with nephrotic syndrome picture + CKD + severe HTN, you need quantification to:
  1. Confirm nephrotic-range proteinuria (≥3.5 g/24h)
  2. Characterize the protein type (albumin-predominant = glomerular vs. light chains = overflow)
  3. Stage and monitor CKD progression
  4. Guide biopsy decision — if UPCR >3.5 g/g, hypoalbuminemia, and no clear secondary cause → renal biopsy is indicated
  5. BP 200/100 with nephrotic-range proteinuria — this level of hypertension is a primary target regardless of etiology (KDIGO recommends BP <130/80 in proteinuric CKD)

Can You Do 24-Hour Urine Protein While the Patient Is on Diuretics?

Why 24-Hour Urine Is Not Invalidated by Diuretics

• The total protein excreted per day reflects glomerular leak — this is determined by the glomerular filtration barrier, not by urine flow rate
• Even with forced diuresis, the protein excreted over 24 hours still represents true daily proteinuria
• The 24-hour collection captures everything regardless of concentration — that's its whole advantage over concentration-dependent tests

The critical concept: diuretics dilute each individual urine sample, but the total amount collected over 24 hours remains accurate for protein excretion.

However — Two Real Problems on Diuretics

Why Spot Urine PCR (Protein:Creatinine Ratio) Is Actually Better Here

• Diuretics dilute urine → if you rely on concentration-based tests (dipstick), they become unreliable
• But the spot PCR corrects for concentration by dividing protein by creatinine in the same sample
• Both protein and creatinine are diluted equally by diuresis → their ratio remains stable and accurate
• This is precisely why KDIGO guidelines endorse spot urine PCR as the preferred method

Spot PCR is not affected by diuretic-induced dilution because protein and creatinine are diluted proportionally in the same sample.

Practical Recommendation for This Patient

Bottom Line

Yes — Absolutely Check Anti-PLA2R. It's One of the Most Clinically Valuable Tests in This Patient.

What Is Anti-PLA2R?

"The M-type phospholipase A2 receptor (PLA2R) is the first podocyte antigen involved in membranous nephropathy to be described in adults. Detection of autoantibodies directed to PLA2R (anti-PLA2R antibody) indicates primary disease rather than a secondary process and guides therapy." — Tietz Textbook of Laboratory Medicine, 7e

Why It Matters Specifically in This 67-Year-Old Male

"In patients older than 60 years, MN is associated with a malignancy in 20–30% of patients... The most common malignancies were cancers of the lung and prostate. The frequency of malignancy increased with age." — Brenner and Rector's The Kidney, 2-Volume Set

• Carcinoma lung (CXR/CT chest)
• Carcinoma prostate (PSA, DRE)
• Carcinoma colon (colonoscopy)
• Hepatitis B & C serology
• SLE (ANA, dsDNA)
• Drugs (gold, penicillamine, captopril — note: captopril is an ACE inhibitor; ask about medications)

Clinical Utility of Anti-PLA2R

Important Caveats

1. Sensitivity is ~70–80% — a negative result does NOT exclude primary MN; biopsy is still required for definitive diagnosis
2. Sensitivity decreases if the patient is already in partial remission (spontaneous or treatment-induced)
3. Anti-THSD7A is another podocyte antibody found in ~3–5% of anti-PLA2R-negative primary MN — also associated with malignancy (especially gynecological tumors); worth checking if PLA2R negative
4. Anti-PLA2R is specific for primary MN only — it is negative in secondary MN (lupus, hepatitis B-associated, malignancy-associated)

Practical Workup Plan for This Patient

Serology panel to send:
├── Anti-PLA2R antibody (serum) ← send immediately
├── Anti-THSD7A (if PLA2R negative)
├── ANA, anti-dsDNA, complement (C3/C4)
├── HBsAg, Anti-HCV
├── SPEP + SIFE (myeloma screen)
├── PSA (prostate cancer screening — 67M!)
├── CXR / CT chest (lung cancer)
└── Renal biopsy → still the gold standard for definitive diagnosis